Michelle L.D. Hanlon is affiliated with For All Moonkind, Inc. a non-profit organization focused on protecting human cultural heritage in outer space. When Apollo 13 looped around the Moon in April ...

Twenty-seven states and counting are on track to participate in the first federal program that will direct funds to families so their children can enroll in private schools and cover other expenses ...

Landen Fortunato vs Christian Hakobyan 2026 ADCC San Diego Open Bovino says Minneapolis suspect appeared to want to do 'maximum damage' Trump threatens 100% tariffs on Canada if it does China deal ...

The University of North Texas has joined the ranks of public schools in the state that cover tuition for some freshmen. Starting this fall, the North Texas Promise program will guarantee four years of ...

In response to fan research that shows a clear desire to see the best golfers competing together more often – as well as timely inquiries from players not currently competing on the PGA TOUR and ...

SOUTHWICK – A request by the Economic Development Commission to the Select Board prompted a discussion by its members about whether the town should participate in the state’s Complete Streets program.

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx will ...

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value ...

Insights generated from this program are intended to support future clinical diagnostic development. CareDx will leverage 10x’s Xenium spatial and Chromium Flex single cell platforms for this ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling BRISBANE, Calif.-- ...

Collaboration will engage leading transplant clinician-scientists to study antibody-mediated rejection (AMR) and microvascular inflammation (MVI) using cellular-resolution profiling CareDx, Inc.